medigraphic.com
Instituto Nacional de Salud Pública

2007, Number S2

<< Back Next >>

salud publica mex 2007; 49 (S2)

Withdrawal symptoms indicators in a group of mexican smokers

Lara-Rivas G, Ramírez-Venegas A, Sansores-Martínez RH, Espinosa AM, Regalado-Pineda J

Language: Spanish
References: 23
Page: 257-562
PDF size: 155.48 Kb.


ABSTRACT

Objective. To describe symptoms of AS in a group of Mexican smokers attending a third referral clinic, to evaluate symptoms according to degree of nicotine dependence using the Fagerström Test (FTND). Material and Methods. A self-reported standardized questionnaire was administered to smokers and non-smokers during three consecutive days. None of the smokers received treatment during this period. Results. A total of 185 smokers and 102 non-smokers were included. No differences in age or gender were observed. Among smokers, median tobacco consumption was 13 pack-years (range 1 to 72) and the mean (SD) FTND was six (2.35). Symptoms related to nicotine withdrawal were anxiety (OR 1.21, 95%IC 1.03–1.43), depression (OR 2.75, 95%IC 1.07–7.04), which was more common in women (OR 2.03, 95%IC 1.10–3.75), urge to smoke (OR 1.53, 95%IC 1.19–1.97), and sweating (OR 2.73, 95%IC 1.07–6.95). Conclusions. The most frequent symptoms related to nicotine abstinence in Mexican smokers were: anxiety, urge to smoke, depression and sweating. These symptoms correlate with the degree of addiction.


REFERENCES

  1. World Health Organization. The smoking epidemic: a fire in the global village. 25th August, Press Release WHO/ 61. Geneve: WHO,1997.

  2. Secretaría de Salud. Dirección General de Epidemiología. Dirección General de Estadística e Informática. México: SSA, 2004.

  3. Secretaría de Salud. Consejo Nacional Contra las Adicciones (CONADIC). Encuesta Nacional de Adicciones 2002. Tabaco, alcohol y otras drogas. Resumen Ejecutivo. México: SSA, 2002.

  4. US Department of Health and Human Services. Reducing the health consequences of smoking. 25 years of progress. A Report of the Surgeon General. Washington, DC: US Government Printing Office,1989.

  5. Kuri PM, Alegre DJ, Mata MA, Hernández AM. Mortalidad atribuible al consumo de tabaco en México. Salud Publica Mex 2002; 44 (Suplemento 1):S 29-33.

  6. Shoaib M, Schindler CW, Goldberg SR. Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 1997; 129:35-43.

  7. Henningfield D, Goldberg SR. Nicotine as reinforcement in human subjects and laboratory animals. Pharmacol Biochem Behav 1983;19:989-992.

  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition ,(DSM-IV). Arlington, Va: APA, 1994.

  9. Hughes JR. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 2007;9(3):329-39.

  10. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry 1991;48:52-59.

  11. Ward MM, Swan GE, Jack LM. Self- reported abstinence effects in the first month after smoking cessation. Addictive Behaviors 2001;26:311-327.

  12. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007;9(3):315-327.

  13. Organización Mundial de la Salud. Décima Revisión de la Clasificación Internacional de las Enfermedades (CIE10). Trastornos Mentales y del Comportamiento. Madrid: Forma, 1993.

  14. Goldberg DP. Standardized Psychiatric Interview (SPI) Institute of Psychiatry, 1969. Cuadernos Científicos CEMESAM 11 1979: 49-50.

  15. Hughes JR. Clinical significance of tobacco withdrawal. Nicotine and Tobacco Research 2006;8(2):153-156.

  16. Camí J, Farré M. Drug addiction. N Engl J Med 2003; 349:975-986.

  17. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol 2007; 15(1):21-36.

  18. Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl) 2006; 187(3):385-396.

  19. Etter JF. A self- administered questionnaire to measure cigarette withdrawal symptoms: The Cigarette Withdrawal Scale. Nicotine Tob Res 2005; 7(1):47-57.

  20. Fagerström KO, Schneider NG. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire. Journal of Behavioral Medicine 1989;12: 159-181.

  21. Etter JF. A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerstrom test for nicotine dependence. Drug Alcohol Depend 2005; 7;77(3):259-268.

  22. West R, Ussher M, Evans M, Rashid M. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl) 2006;184(3-4):619-627.

  23. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin 2005; 21(5):749-760.




2020     |     www.medigraphic.com